These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8027926)

  • 1. Comparative study of buccoadhesive formulations and sublingual capsules of nifedipine.
    Save T; Shah MU; Ghamande AR; Venkitachalam P
    J Pharm Pharmacol; 1994 Mar; 46(3):192-5. PubMed ID: 8027926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics and antihypertensive effects of the nifedipine tablet and capsule.
    Myers MG; Raemsch KD
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S76-8. PubMed ID: 2455148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
    Al-Waili NS; Hasan NA
    Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic comparisons of oral and sublingual nifedipine in hypertensive Mexican patients.
    Palma-Aguirre JA; Roa-Mendieta A; Hernández-Jiménez LM; Girard-Cuesy ME; León-Urrea F; Alfaro-Mejía A; Frati A; Barreiro-Perera O
    Proc West Pharmacol Soc; 1993; 36():137-41. PubMed ID: 8378367
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of sublingual captopril and sublingual nifedipine in hypertensive emergencies.
    Ceyhan B; Karaaslan Y; Caymaz O; Oto A; Oram E; Oram A; Ugurlu S
    Jpn J Pharmacol; 1990 Feb; 52(2):189-93. PubMed ID: 2179605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withdrawal of nifedipine capsules: jeopardising the treatment of acute severe hypertension in pregnancy?
    Langton PE
    Med J Aust; 1998 Jan; 168(1):43-4. PubMed ID: 9451398
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the method for nifedipine administration for a rapid onset of clinical effect: a clinical study in normal volunteers.
    Kubota R; Komiyama T; Shimada H
    Yakugaku Zasshi; 2001 May; 121(5):355-64. PubMed ID: 11360489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of sublingual captopril, nifedipine and prazosin in hypertensive emergencies during hemodialysis.
    Wu SG; Lin SL; Shiao WY; Huang HW; Lin CF; Yang YH
    Nephron; 1993; 65(2):284-7. PubMed ID: 8247194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual nicardipine versus nifedipine to treat hypertensive urgencies.
    Savi L; Montebelli MR; D'Alonzo S; Mettimano M; Folli G
    Int J Clin Pharmacol Ther Toxicol; 1992 Feb; 30(2):41-5. PubMed ID: 1551744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hypertensive emergencies with nifedipine.
    Karachalios GN; Donas G; Tsimiklis S; Stathakakis V
    Int J Clin Pharmacol Ther Toxicol; 1988 Jul; 26(7):351-5. PubMed ID: 3209283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial.
    Angeli P; Chiesa M; Caregaro L; Merkel C; Sacerdoti D; Rondana M; Gatta A
    Arch Intern Med; 1991 Apr; 151(4):678-82. PubMed ID: 2012448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sublingual captopril versus nifedipine in the treatment of hypertensive crisis].
    Pérez C; Dougnac A; Alvarez M; Andresen M; Díaz O; Geni R; Prat G; Vásquez M
    Rev Med Chil; 1991 Apr; 119(4):402-5. PubMed ID: 1842983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?
    Grossman E; Messerli FH; Grodzicki T; Kowey P
    JAMA; 1996 Oct 23-30; 276(16):1328-31. PubMed ID: 8861992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and dynamics of nifedipine after oral and sublingual doses.
    McAllister RG
    Am J Med; 1986 Dec; 81(6A):2-5. PubMed ID: 3799661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic differences between nifedipine capsule and GITS formulations in hypertensive patients.
    Isordia I; Carrasco M; Chávez-Negrete A; Palma-Aguirre JA; Flores-Murrieta FJ; Castañeda-Hernández G
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):133. PubMed ID: 9089004
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of hypertensive emergencies and crisis with sublingual nifedipine].
    Domínguez B; Díaz R
    Rev Med Panama; 1988 May; 13(2):100-6. PubMed ID: 3194548
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparative study of the acute antihypertensive effect of Adalat capsules and Corinfar dragées, two different nifedipine preparations.
    Kiss I; Farsang C
    Cor Vasa; 1988; 30(2):105-9. PubMed ID: 3391034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual and intravenous ketanserin versus sublingual nifedipine in the treatment of severe hypertension: a randomized study.
    Sechi LA; Tedde R; Cassisa L; Pala A; Orecchioni C; Uneddu F; Melis A
    Clin Ther; 1989; 11(6):834-40. PubMed ID: 2692825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertensive crisis: comparative study of oral captopril, sublingual captopril and sublingual nifedipine].
    Martínez Amenós A; Carratalà J; Pintó X; Santaló M; Tamayo C; Pujol M
    Med Clin (Barc); 1987 Jun; 89(2):59-61. PubMed ID: 3302561
    [No Abstract]   [Full Text] [Related]  

  • 20. Negligible sublingual absorption of nifedipine.
    van Harten J; Burggraaf K; Danhof M; van Brummelen P; Breimer DD
    Lancet; 1987 Dec; 2(8572):1363-5. PubMed ID: 2890954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.